...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: plenty of scenarios being put out there...
Reply New Message
Prev Message Back To Forum Threaded View Next Message
My guess is DM might have been thinking with sales in China of 5 billion at 6% = 300 million in royalties. With two similar deals made, it would amount to around a billion a year, right?
1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply